HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Use of rasburicase in a pregnant woman with acute lymphoblastic leukaemia and imminent tumour lysis syndrome.

AuthorsJan Moritz Middeke, Normi Bruck, Stefani Parmentier, Martin Bornhäuser, Johannes Schetelig
JournalAnnals of hematology (Ann Hematol) Vol. 93 Issue 3 Pg. 531-2 (Mar 2014) ISSN: 1432-0584 [Electronic] Germany
PMID23820942 (Publication Type: Case Reports, Letter)
Chemical References
  • Recombinant Proteins
  • Uricosuric Agents
  • rasburicase
  • Urate Oxidase
Topics
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cesarean Section
  • Fatal Outcome
  • Female
  • Humans
  • Hyperuricemia (etiology, prevention & control)
  • Live Birth
  • Postpartum Period
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (drug therapy, physiopathology)
  • Pregnancy
  • Pregnancy Complications, Neoplastic (physiopathology)
  • Pregnancy Trimester, Third
  • Recombinant Proteins (therapeutic use)
  • Risk
  • Tumor Lysis Syndrome (epidemiology, etiology, physiopathology, prevention & control)
  • Urate Oxidase (therapeutic use)
  • Uricosuric Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: